HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry
Business Model:
Revenue: $5.9M
Employees: 11-50
Address: 3000 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry, including medical devices, biopharma, healthcare services, and healthcare IT
Contact Phone:
+16506818420
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | RareCyte | Series G | 0 |
7/2015 | Castle Biosciences | Series F | 11.7M |
11/2022 | Venus Concept | Post-IPO Equity | 6.7M |
1/2019 | Trice Medical | Series C | 0 |
7/2017 | Venus Concept | Venture Round | 0 |
3/2016 | Spirox | Series C | 45M |
10/2016 | Avizia | Series A | 6M |
11/2019 | Venus Concept | Private Placement | 28M |
6/2017 | Trice Medical | Series C | 0 |
1/2015 | Trice Medical | Series B | 6.5M |
7/2016 | Magnolia Medical Technologies | Series B | 13.8M |
5/2020 | Pulmonx | Equity | 66M |
1/2021 | EverlyWell | Series D | 75M |
7/2018 | Ajax Health | Series B | 120M |
1/2023 | Perspectum | Series C | 37.4M |
4/2020 | Perspectum | Series B | 35.9M |
1/2018 | Springbuk | Series B | 20M |
4/2017 | Avedro | Venture Round | 0 |
6/2021 | Thirty Madison | Series C | 0 |
11/2015 | First Aid Shot Therapy | Series C | 24M |
2/2016 | Vestagen Technical Textiles | Venture Round | 7M |
4/2019 | Ajax Health | Series C | 85M |
7/2016 | Avizia | Series A | 11M |
1/2019 | Harmony Home Health | Private Equity Round | - |
3/2018 | BioIQ | Venture Round | 26.5M |
10/2017 | Vestagen Technical Textiles | Venture Round | 0 |
9/2015 | Vestagen Technical Textiles | Convertible Note | 3.3M |
1/2019 | Magnolia Medical Technologies | Series C | 0 |
8/2014 | Castle Biosciences | Venture Round | 11.8M |
1/2015 | Lineagen | Series C | 0 |
1/2016 | Biotheranostics | Venture Round | 32M |
6/2022 | Nomad Health | Venture Round | 0 |
2/2022 | Magnolia Medical Technologies | Venture Round | 0 |
5/2018 | Avedro | Series F | 0 |
5/2018 | CleanSlate | Equity | 25M |
11/2021 | Lunit | Venture Round | 0 |
12/2019 | RareCyte | Equity | 22M |
1/2023 | Clearsense | Series D | 50M |
6/2019 | Ajax Health | Series C | 15M |
10/2015 | inMediata | Venture Round | 4M |
10/2020 | TigerConnect | Series D | 0 |
9/2017 | Alcresta | Series C | 60M |
4/2019 | Bardy Diagnostics | Series B | 35.5M |
6/2022 | Nomad Health | Venture Round | 0 |
2/2022 | Magnolia Medical Technologies | Venture Round | 0 |
11/2021 | Lunit | Venture Round | 0 |
9/2021 | RareCyte | Series G | 0 |
6/2021 | Thirty Madison | Series C | 0 |
1/2021 | EverlyWell | Secondary Market | 0 |
10/2020 | TigerConnect | Series D | 0 |
5/2020 | Pulmonx | Series H | 0 |
4/2020 | Perspectum | Series B | 0 |
12/2019 | RareCyte | Series F | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|